Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | 5542285 |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Genetic Analysis AS' ("GA" or the "Company") subsequent offering to existing shareholders, for which the subscription period ended on December 22, 2023 (the "Subsequent Offering"), has now been registered with the Norwegian Register of Business Enterprises (No. Foretaksregisteret).
During the period December 11 - December 22, 2023, GA carried out the Subsequent Offering that provided the Company with approximately NOK 3.1 million by issuance of 3,958,036 new shares, before issue costs. The Subsequent Offering has now been registered with the Norwegian Register of Business Enterprises.
After this, the Company's new registered share capital is NOK 25,294,413 divided into 42,157,355 shares, each with a nominal value of NOK 0.60.
Advisors
In connection with the Subsequent Offering, Sedermera Corporate Finance AB (www.sedermera.se) is appointed Swedish financial advisor and Advokatfirmaet Wiersholm AS is the Company's Norwegian legal advisor.